Detalhe da pesquisa
1.
Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.
J Clin Oncol
; 34(36): 4345-4353, 2016 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27998236
2.
Heregulin-ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells.
Mol Cancer Ther
; 14(9): 2072-80, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26116360